Day: July 25, 2018


Understanding and Avoiding Common Phase 3 Failure Points

  • July 25, 2018
  • |

By the time the drug development process gets to Phase 3, it seems reasonable to assume that the chance of failure is relatively low. After all, the entire early-development process is at least partially designed to reduce the risk of failure of the longer and more expensive clinical trials. The knowledge gained from the data […] READ MORE...